ARCHIVES

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 11 | March 12, 1976

Download PDF Visit The Full Archive

Related Articles

Estrogen Can Benefit Women With Metastatic Breast Cancer

January 30, 2009

Consortium Centers Pose Problems To Some, But claim They “Coincide With Congress’ Intent”

December 9, 1977

BSA Strikes Down NCI Tissue Bank Plan, Calls for Audit of caBIG

March 11, 2011

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976

Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm

May 8, 2009